Free Trial

Oracle (ORCL) Stock Forecast & Price Target

Oracle logo
$230.45 -4.55 (-1.94%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$230.05 -0.40 (-0.17%)
As of 07/11/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oracle - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
8
Buy
25

Based on 33 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 33 analysts, 8 have given a hold rating, 23 have given a buy rating, and 2 have given a strong buy rating for ORCL.

Consensus Price Target

$209.33
-9.16% Downside
According to the 33 analysts' twelve-month price targets for Oracle, the average price target is $209.33. The highest price target for ORCL is $275.00, while the lowest price target for ORCL is $130.00. The average price target represents a forecasted downside of -9.16% from the current price of $230.45.
Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

Sign Up

ORCL Analyst Ratings Over Time

TypeCurrent Forecast
7/13/24 to 7/13/25
1 Month Ago
6/13/24 to 6/13/25
3 Months Ago
4/14/24 to 4/14/25
1 Year Ago
7/14/23 to 7/13/24
Strong Buy
2 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
23 Buy rating(s)
21 Buy rating(s)
16 Buy rating(s)
17 Buy rating(s)
Hold
8 Hold rating(s)
10 Hold rating(s)
12 Hold rating(s)
13 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$209.33$195.39$178.27$145.83
Forecasted Upside-9.16% Downside-9.35% Downside32.71% Upside0.73% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oracle Stock vs. The Competition

TypeOracleComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.82
2.66
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-9.16% Downside82.07% Upside10.52% Upside
News Sentiment Rating
Positive News

See Recent ORCL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/10/2025Piper Sandler
2 of 5 stars
B. Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$190.00 ➝ $270.00+14.18%
7/3/2025TD Cowen
4 of 5 stars
Derrick Wood
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$250.00 ➝ $275.00+18.06%
7/2/2025BMO Capital Markets
4 of 5 stars
K. Bachman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$235.00 ➝ $245.00+11.81%
6/30/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Reback
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$180.00 ➝ $250.00+18.96%
6/25/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Karl Keirstead
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetBuy ➝ Buy$225.00 ➝ $250.00+17.03%
6/18/2025Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Hold
6/18/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight
6/18/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy
6/18/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform
6/18/2025Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingStrong-Buy ➝ Strong-Buy
6/18/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Difucci
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$220.00 ➝ $250.00+17.12%
6/13/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kash Rangan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$145.00 ➝ $195.00-6.49%
6/13/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Raimo Lenschow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$202.00 ➝ $221.00+10.68%
6/12/2025Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy
6/12/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform
6/12/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Jaluria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Perform ➝ Sector Perform$145.00 ➝ $195.00-2.91%
6/12/2025DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gil Luria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$140.00 ➝ $170.00-15.32%
6/12/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Murphy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$135.00 ➝ $185.00-8.06%
6/12/2025JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Patrick Walravens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetMarket Outperform ➝ Market Outperform$205.00 ➝ $240.00+19.28%
6/12/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$156.00 ➝ $220.00+24.76%
6/12/2025Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Zelnick
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$200.00 ➝ $240.00+36.11%
6/12/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jackson Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$200.00 ➝ $225.00+27.60%
6/12/2025Westpark Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Shauger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$195.00 ➝ $246.00+39.51%
6/10/2025Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Murphy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$135.00-23.99%
6/9/2025CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy
6/9/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Thill
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$190.00 ➝ $200.00+12.55%
4/15/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Siti Panigrahi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$210.00 ➝ $180.00+34.00%
3/19/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brett Huff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$167.00+11.72%
3/11/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Blakey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$214.00 ➝ $175.00+25.43%
3/3/2025Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. White
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
12/10/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
9/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$201.00 ➝ $202.00+19.71%
9/16/2024Melius Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
6/18/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$145.00 ➝ $159.00+11.83%
3/13/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$144.00 ➝ $155.00+21.42%
3/12/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Naji
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
12/22/2023Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
12/12/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$140.00 ➝ $130.00+12.96%
11/13/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/21/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$82.50 ➝ $110.00-2.54%
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
9/14/2023DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$125.00+11.77%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:40 PM ET.


Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 8, 2025. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Oracle:

  • The current stock price is around $234, reflecting a recent increase, which may indicate positive market sentiment towards Oracle.
  • Oracle reported a strong quarterly earnings performance, with earnings per share (EPS) of $1.70, surpassing analysts' expectations, which suggests robust financial health.
  • The company has shown a year-over-year revenue growth of over 11%, indicating a solid demand for its products and services.
  • Oracle's market capitalization stands at approximately $659 billion, showcasing its significant presence and stability in the enterprise software market.
  • Recent investments from institutional investors, including a notable purchase of shares by Consolidated Capital Management, reflect confidence in Oracle's future prospects.

Oracle
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Oracle for these reasons:

  • The company has a high debt-to-equity ratio of 4.07, which may raise concerns about its financial leverage and ability to manage debt effectively.
  • Insider selling has been significant, with executives selling over 450,000 shares recently, which could signal a lack of confidence in the company's short-term performance.
  • Despite positive earnings, the stock has a high price-to-earnings (P/E) ratio of 54.06, suggesting that it may be overvalued compared to its earnings potential.
  • Market volatility, as indicated by a beta of 1.39, suggests that Oracle's stock price may be more susceptible to fluctuations compared to the overall market.
  • Analysts have mixed ratings, with a consensus of "Moderate Buy," indicating that while some see potential, others may have reservations about the stock's future performance.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 33 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $209.33, with a high forecast of $275.00 and a low forecast of $130.00.

33 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last twelve months. There are currently 8 hold ratings, 23 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted downside of -9.16% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 3 upgrades by analysts.

Analysts like Oracle more than other "computer and technology" companies. The consensus rating score for Oracle is 2.82 while the average consensus rating score for "computer and technology" companies is 2.66. Learn more on how ORCL compares to other companies.


This page (NYSE:ORCL) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners